Clinical trial
The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered…
NCT00359216 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00359216 |
|---|---|
| Title | The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726) |
| Official title | A Double-Blind Placebo-Controlled, Randomized, Parallel-Group, Single-Site Study of Mometasone Furoate Nasal Spray (MFNS) In Subjects With Sleep-disordered Breathing Associated With Perennial Allergic Rhinitis (PAR) Using Home-Monitored Cardio-Respiratory Methodology. |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Perennial Allergic Rhinitis, Obstructive Sleep Apnea, Sleep Disorder |
| Intervention type | Drug |
| Interventions | Mometasone furoate nasal spray, Placebo |
| Enrollment | 30 |
| Start date | May 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Aug 1, 2006 |
| Last update posted | May 23, 2024 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: